Stay updated on Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T13:22:30.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T14:20:05.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the study details, indicating an access-restriction page is being served.
    Difference
    17%
    Check dated 2026-09-20T19:59:54.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.6.6. This indicates a small update to the page version and does not change the study content or data.
    Difference
    0.1%
    Check dated 2026-08-30T10:25:28.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page revision label changed from Revision: v3.6.4 to Revision: v3.6.5, indicating a new page version. This is a maintenance update that does not alter the study information.
    Difference
    0.1%
    Check dated 2026-08-08T23:08:22.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The page revision was updated to v3.6.4 from v3.6.3, indicating a small update to the page's content/UI.
    Difference
    0.1%
    Check dated 2026-07-25T13:13:09.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page.